{"id":441577,"date":"2021-02-23T07:03:18","date_gmt":"2021-02-23T12:03:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441577"},"modified":"2021-02-23T07:03:18","modified_gmt":"2021-02-23T12:03:18","slug":"repare-therapeutics-announces-march-2021-virtual-investor-conference-participation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/","title":{"rendered":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation <\/b><\/p>\n<p>CAMBRIDGE, Mass. &amp; MONTREAL&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nRepare Therapeutics Inc. (\u201cRepare\u201d or the \u201cCompany\u201d) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows:\n<\/p>\n<p><b>Cowen 41st Annual Health Care Conference<br \/>\n<br \/><\/b>Panel Discussion Title: Ovarian Cancer<br \/>\n<br \/>Date: Tuesday, March 2, 2021<br \/>\n<br \/>Time: 12:50 p.m. Eastern Time\n<\/p>\n<p><b>H.C. Wainwright Annual Global Life Sciences Conference<br \/>\n<br \/><\/b>Date: Tuesday, March 9 \u2013 Wednesday, March 10, 2021\n<\/p>\n<p><b>Morgan Stanley Virtual Healthcare Corporate Access Day<br \/>\n<br \/><\/b>Date: Tuesday, March 16, 2021\n<\/p>\n<p>\nThe prerecorded H.C. Wainwright presentation will be available on Tuesday, March 9, 2021, at 7:00 a.m. Eastern Time in the Investor section of the Company\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.reparerx.com%2Fnews-and-events%2Fevents&amp;esheet=52383395&amp;newsitemid=20210223005218&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.reparerx.com%2Fnews-and-events%2Fevents&amp;index=1&amp;md5=bf405928226d13b880473efcda62f3a2\">https:\/\/ir.reparerx.com\/news-and-events\/events<\/a>. A replay of the webcast will be archived on the Company\u2019s website for 30 days.\n<\/p>\n<p><b>About Repare Therapeutics, Inc.<\/b><\/p>\n<p>\nRepare Therapeutics is a leading clinical-state precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx\u00ae platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company\u2019s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1\/2 clinical development, as well as RP-6306, a CCNE1-SL inhibitor and a Pol\u03b8 inhibitor program. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.reparerx.com%2F&amp;esheet=52383395&amp;newsitemid=20210223005218&amp;lan=en-US&amp;anchor=reparerx.com&amp;index=2&amp;md5=7db81bab07b5bf020daeb9036e39dd92\">reparerx.com<\/a>.\n<\/p>\n<p>\nSNIPRx\u00ae is a registered trademark of Repare Therapeutics Inc.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210223005218\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210223005218\/en\/<\/a><\/span><\/p>\n<p><b>Repare Contact: <\/b><\/p>\n<p>\nSteve Forte<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/>Repare Therapeutics Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:info@reparerx.com\">info@reparerx.com <\/a><\/p>\n<p><b>Investors: <\/b><\/p>\n<p>\nKimberly Minarovich<br \/>\n<br \/>Argot Partners<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:repare@argotpartners.com\">repare@argotpartners.com <\/a><\/p>\n<p><b>Media: <\/b><\/p>\n<p>\nDavid Rosen<br \/>\n<br \/>Argot Partners<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:david.rosen@argotpartners.com\">david.rosen@argotpartners.com<br \/>\n<\/a><br \/>212-600-1902\n<\/p>\n<p><b>KEYWORDS:<\/b> Massachusetts United States North America Canada<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Health Pharmaceutical Clinical Trials Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation CAMBRIDGE, Mass. &amp; MONTREAL&#8211;(BUSINESS WIRE)&#8211; Repare Therapeutics Inc. (\u201cRepare\u201d or the \u201cCompany\u201d) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows: Cowen 41st Annual Health Care Conference Panel Discussion Title: Ovarian Cancer Date: Tuesday, March 2, 2021 Time: 12:50 p.m. Eastern Time H.C. Wainwright Annual Global Life Sciences Conference Date: Tuesday, March 9 \u2013 Wednesday, March 10, 2021 Morgan Stanley Virtual Healthcare Corporate Access Day Date: Tuesday, March 16, 2021 The prerecorded H.C. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441577","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation CAMBRIDGE, Mass. &amp; MONTREAL&#8211;(BUSINESS WIRE)&#8211; Repare Therapeutics Inc. (\u201cRepare\u201d or the \u201cCompany\u201d) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows: Cowen 41st Annual Health Care Conference Panel Discussion Title: Ovarian Cancer Date: Tuesday, March 2, 2021 Time: 12:50 p.m. Eastern Time H.C. Wainwright Annual Global Life Sciences Conference Date: Tuesday, March 9 \u2013 Wednesday, March 10, 2021 Morgan Stanley Virtual Healthcare Corporate Access Day Date: Tuesday, March 16, 2021 The prerecorded H.C. &hellip; Continue reading &quot;Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T12:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation\",\"datePublished\":\"2021-02-23T12:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/\",\"name\":\"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-02-23T12:03:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/","og_locale":"en_US","og_type":"article","og_title":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk","og_description":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation CAMBRIDGE, Mass. &amp; MONTREAL&#8211;(BUSINESS WIRE)&#8211; Repare Therapeutics Inc. (\u201cRepare\u201d or the \u201cCompany\u201d) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team are scheduled to participate in three virtual investor conferences in March. Details are as follows: Cowen 41st Annual Health Care Conference Panel Discussion Title: Ovarian Cancer Date: Tuesday, March 2, 2021 Time: 12:50 p.m. Eastern Time H.C. Wainwright Annual Global Life Sciences Conference Date: Tuesday, March 9 \u2013 Wednesday, March 10, 2021 Morgan Stanley Virtual Healthcare Corporate Access Day Date: Tuesday, March 16, 2021 The prerecorded H.C. &hellip; Continue reading \"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T12:03:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation","datePublished":"2021-02-23T12:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/"},"wordCount":330,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/","name":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-02-23T12:03:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210223005218r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repare-therapeutics-announces-march-2021-virtual-investor-conference-participation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Repare Therapeutics Announces March 2021 Virtual Investor Conference Participation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441577"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441577\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}